Verified Nov 2026
Batteries & E-Mobility
·
St. Louis, Missouri
·
Since 2013
Acera Surgical is a bioscience company headquartered in St. Louis, Missouri, United States, founded in 2013. It develops and commercializes fully synthetic electrospun fiber matrices for soft-tissue repair and regenerative wound care, with products free of animal and human components. The company reports an estimated revenue band of $50-100 million and 200-500 employees, and serves the medical, automotive, electric-vehicle, and industrial-equipment sectors. Its FDA-cleared Restrata matrix was reported in 2026 to have received 510(k) clearance for combined use with Solventum's V.A.C. Therapy system. The company is privately held and was acquired by Solventum, which completed the transaction in December 2025.
Acera Surgical at a glance
Revenue
$50-100M
Est. band
Employees
200-500
Founded
2013
Headquarters
St. Louis, Missouri
Certifications
ISO 13485
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
STABILITY SIGNALS
Established & active
13 years in operation (founded 2013).
Holds ISO 13485 certification(s) per public sources.
Overview
Acera Surgical is a bioscience company headquartered in St. Louis, Missouri, United States, founded in 2013. It develops and commercializes fully synthetic electrospun fiber matrices for soft-tissue repair and regenerative wound care, with products free of animal and human components. The company reports an estimated revenue band of $50-100 million and 200-500 employees, and serves the medical, automotive, electric-vehicle, and industrial-equipment sectors. Its FDA-cleared Restrata matrix was reported in 2026 to have received 510(k) clearance for combined use with Solventum's V.A.C. Therapy system. The company is privately held and was acquired by Solventum, which completed the transaction in December 2025.
At a glance
Attribute | Detail |
|---|---|
Founded | 2013 |
Headquarters | St. Louis, Missouri |
Employees | 200-500 |
Revenue | $50-100M (estimated) |
Primary capability | Batteries & E-Mobility |
Certifications | ISO 13485 |
What Acera Surgical makes
The company holds ISO 13485 certification and produces the Restrata synthetic electrospun fiber matrix for wound management and the Cerafix dural repair matrix.
Products and capabilities described on the company's own site include LED (source: acera-surgical.com).
Certifications
Acera Surgical is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — acera-surgical.com
Latest developments
2026-10-20 — Acera Surgical is proud to share that Restrata™ Synthetic Electrospun Fiber Matrix has received FDA 510(k) clearance for combined use with Solventum™ V.A.C.® Therapy in the United States. This first-of-its-kind clearance brings … | Acera Surgical (linkedin.com)
2026-08-21 — Transforming patient lives through expanded access. | Acera Surgical (linkedin.com)
2026-08-13 — We're Growing Our Independent Distributor Network. | Acera Surgical (linkedin.com)
2026-01-06 — McDermott Will & Schulte advises Solventum in its acquisition of Acera Surgical | McDermott (mcdermottlaw.com)
2025-12-23 — Solventum Completes Acquisition of Acera Surgical :: Solventum Corporation (SOLV) (solventum.com)
2025-11-24 — Solventum to buy Acera Surgical for up to $850M, repurchase $1B in stock (fiercebiotech.com)
Company details
Acera Surgical is privately held and was acquired by Solventum; its products are used in surgical, traumatic, and chronic wound care as well as neurological dural repair. Acera Surgical was founded in 2013, has an estimated 200-500 employees, and is headquartered in St. Louis, Missouri. On the LightSource stability read it is rated "Established & active": 13 years in operation (founded 2013). Holds ISO 13485 certification(s) per public sources.
Frequently asked questions
What does Acera Surgical make?
Acera Surgical is a bioscience company headquartered in St. Louis, Missouri, United States, founded in 2013. It develops and commercializes fully synthetic electrospun fiber matrices for soft-tissue repair and regenerative wound care, with products free of animal and human components. The company reports an estimated revenue band of $50-100 million and 200-500 employees, and serves the medical, automotive, electric-vehicle, and industrial-equipment sectors. Its FDA-cleared Restrata matrix was reported in 2026 to have received 510(k) clearance for combined use with Solventum's V.A.C. Therapy system. The company is privately held and was acquired by Solventum, which completed the transaction in December 2025.
Where is Acera Surgical headquartered?
Acera Surgical is headquartered in St. Louis, Missouri (1650 Des Peres Rd, St. Louis, Missouri, 63131-1821).
When was Acera Surgical founded?
Acera Surgical was founded in 2013.
How big is Acera Surgical?
Acera Surgical has an estimated 200-500 employees, with revenue in the $50-100M range (estimated).
What certifications does Acera Surgical hold?
Acera Surgical lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.